Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kostas Biliouris is an analyst at BMO Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/23/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/18/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $17.00 | 135.32% | $63 → $40 | Maintains | Outperform | Get Alert |
| 07/03/2024 | LEGN | Buy Now | Legend Biotech | $58.93 | 52.72% | $90 → $90 | Maintains | Outperform | Get Alert |
| 06/24/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $235.59 | -0.67% | $234 → $234 | Maintains | Outperform | Get Alert |
| 06/24/2024 | SRPT | Buy Now | Sarepta Therapeutics | $146.35 | 36.66% | $170 → $200 | Maintains | Outperform | Get Alert |
| 06/18/2024 | SRPT | Buy Now | Sarepta Therapeutics | $146.35 | 16.16% | $170 → $170 | Maintains | Outperform | Get Alert |
| 06/14/2024 | SRPT | Buy Now | Sarepta Therapeutics | $146.35 | 16.16% | $170 → $170 | Maintains | Outperform | Get Alert |
| 05/15/2024 | KRRO | Buy Now | Korro Bio | $48.38 | 148.04% | → $120 | Maintains | Outperform | Get Alert |
| 05/10/2024 | NTLA | Buy Now | Intellia Therapeutics | $25.45 | 175.05% | $62 → $70 | Maintains | Outperform | Get Alert |
| 04/01/2024 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.40 | 59.57% | $15 → $15 | Maintains | Outperform | Get Alert |
| 04/01/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $17.00 | 270.63% | $70 → $63 | Maintains | Outperform | Get Alert |
| 03/27/2024 | BEAM | Buy Now | Beam Therapeutics | $27.48 | 107.42% | → $57 | Maintains | Outperform | Get Alert |
| 03/27/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $235.59 | -0.67% | $234 → $234 | Maintains | Outperform | Get Alert |
| 03/26/2024 | KRRO | Buy Now | Korro Bio | $48.38 | 148.04% | $120 → $120 | Reiterates | Outperform → Outperform | Get Alert |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $4.50 | 388.89% | → $22 | Initiates | → Outperform | Get Alert |
| 02/27/2024 | KRRO | Buy Now | Korro Bio | $48.38 | 148.04% | → $120 | Initiates | → Outperform | Get Alert |
| 02/05/2024 | FDMT | Buy Now | 4D Molecular Therapeutics | $17.00 | 311.81% | $50 → $70 | Maintains | Outperform | Get Alert |
| 01/31/2024 | BBIO | Buy Now | BridgeBio Pharma | $26.67 | 38.73% | → $37 | Initiates | → Market Perform | Get Alert |
| 01/31/2024 | SLN | Buy Now | Silence Therapeutics | $21.42 | 212.79% | → $67 | Initiates | → Outperform | Get Alert |
| 01/31/2024 | SRPT | Buy Now | Sarepta Therapeutics | $146.35 | 16.16% | → $170 | Initiates | → Outperform | Get Alert |
| 11/10/2023 | NTLA | Buy Now | Intellia Therapeutics | $25.45 | 143.62% | $64 → $62 | Maintains | Outperform | Get Alert |
| 11/03/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.31 | 17.22% | $102 → $100 | Maintains | Outperform | Get Alert |
| 10/10/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $235.59 | -0.67% | $250 → $234 | Maintains | Outperform | Get Alert |
| 10/09/2023 | PRME | Buy Now | Prime Medicine | $5.48 | 246.72% | → $19 | Initiates | → Outperform | Get Alert |
| 07/25/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.40 | 59.57% | $11 → $15 | Maintains | Outperform | Get Alert |
| 07/05/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.31 | 19.56% | → $102 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/05/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $235.59 | 6.12% | $200 → $250 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/05/2023 | NTLA | Buy Now | Intellia Therapeutics | $25.45 | 151.48% | $57 → $64 | Maintains | Outperform | Get Alert |
| 04/25/2023 | LEGN | Buy Now | Legend Biotech | $58.93 | 52.72% | $79 → $90 | Maintains | Outperform | Get Alert |
| 03/14/2023 | DTIL | Buy Now | Precision BioSciences | $10.44 | -61.69% | $210 → $120 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/14/2023 | NTLA | Buy Now | Intellia Therapeutics | $25.45 | 123.97% | $54 → $57 | Upgrade | Market Perform → Outperform | Get Alert |
| 03/07/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.31 | 19.56% | $107 → $102 | Maintains | Market Perform | Get Alert |
| 01/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $85.31 | 25.42% | → $107 | Initiates | → Market Perform | Get Alert |
| 01/30/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $17.00 | 194.15% | → $50 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | GRPH | Buy Now | Graphite Bio | — | — | $98 → $49 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/20/2022 | BEAM | Buy Now | Beam Therapeutics | $27.48 | 140.17% | $61 → $66 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/11/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.40 | 17.02% | $19 → $11 | Maintains | Outperform | Get Alert |
| 07/18/2022 | VERV | Buy Now | Verve Therapeutics | $7.27 | 753.24% | $48 → $62 | Maintains | Outperform | Get Alert |
| 06/17/2022 | LEGN | Buy Now | Legend Biotech | $58.93 | 30.66% | → $77 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | VERV | Buy Now | Verve Therapeutics | $7.27 | 560.57% | → $48 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | CRSP | Buy Now | CRISPR Therapeutics | $56.70 | 72.84% | → $98 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.40 | 102.13% | → $19 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | DTIL | Buy Now | Precision BioSciences | $10.44 | -32.95% | → $210 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | GRPH | Buy Now | Graphite Bio | — | — | → $84 | Initiates | → Outperform | Get Alert |
| 06/17/2022 | BEAM | Buy Now | Beam Therapeutics | $27.48 | 49.2% | → $41 | Initiates | → Market Perform | Get Alert |
| 06/17/2022 | NTLA | Buy Now | Intellia Therapeutics | $25.45 | 112.18% | → $54 | Initiates | → Market Perform | Get Alert |
